Health News

Title Date
Celebrex and Lipitor against prostate cancer 02/16/10
Two widely used drugs - cholesterol-lowering (Lipitor) and anti-inflammatory (Celebrex ) - may be effective in the treatment of prostate cancer.
Allegra Antihistamine drug of the third millennium 02/03/10
In 1996, the U.S. market saw the launch of the first representative of the third-generation antihistamines named Allegra (fexofenadine), which is the original drug of Aventis Pharma. In 2000, sales of Allegra amounted to 1.166 billion Euro around the worl
Amoxicillin, the drug of first choice in infectious and inflammatory diseases in children 02/03/10
Published results of a randomized international study involving 1,702 patients aged 3-59 months with severe pneumonia showed that treatment regimens with the use of parenteral penicillin and oral doses of amoxicillin did not differ in effectiveness.
Actonel - the FDA approved drug for osteoporosis treatment 01/25/10
In 2000, the FDA approved 5 mg Actonel (risedronate sodium) in tablets to be used in the treatment of osteoporosis in postmenopausal women. In addition, Actonel is approved for treatment of osteoporosis induced by glucocorticoids.
Actonel in a monthly dosage of 75mg 01/25/10
Actonel in a monthly dosage of 75mg when taken for 2 consecutive days is as effective and safe as Actonel at a dosage of 5mg taken daily, showed a study published in the recent edition of the Osteoporosis International. The researchers note that since pat
Washington State insurers impose double digit rate hikes, again 08/03/09
"In what is becoming an annual ordeal for policyholders, Regence BlueShield is raising premiums for 135,000 individual health-plan members in Washington [state] by an average 17 percent on Aug. 1," the Seattle Times reports.
Accelerating the development of new cancer drugs 08/03/09
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The Uni
Antidepressant use becoming more common in the United States 08/03/09
A marked and broad expansion in antidepressant treatment occurred among Americans older than 6 years between 1996 and 2005, although treatment rates remain low among racial and ethnic minorities, according to a report in the August issue of Archives of Ge
Carbon nanosensor sniffs out kidney disease 08/03/09
A carbon nanosensor "electronic nose" - first developed by Technion-Israel Institute of Technology researchers to detect cancer from breath samples - has been modified to identify chronic renal failure (CRF).
Depression among preschoolers - may continue into childhood 08/03/09
Depression among preschoolers appears to be a continuous, chronic condition rather than a transient developmental stage, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Exercise for the brain may slow dementia 08/03/09
People who engage in activities that exercise the brain, such as reading, writing, and playing card games, may delay the rapid memory decline that occurs if they later develop dementia, according to a study published in the August 4, 2009, print issue of
Best Sellers
  1. Sildenafil
  2. Vardenafil
  3. Tadalafil
  4. Xenical
  5. Zyrtec
  6. Valtrex
  7. Tamiflu
  8. Lipitor
Recent News
02/16/10
Celebrex and Lipitor against prostate cancer
Two widely used drugs - cholesterol-lowering (Lipitor) and anti-inflammatory (Celebrex ) - may be effective in the treatment of prostate cancer.
read more ...
02/03/10
Allegra Antihistamine drug of the third millennium
In 1996, the U.S. market saw the launch of the first representative of the third-generation antihistamines named Allegra (fexofenadine), which is the original drug of Aventis Pharma. In 2000, sales of Allegra amounted to 1.166 billion Euro around the worl
read more ...
02/03/10
Amoxicillin, the drug of first choice in infectious and inflammatory diseases in children
Published results of a randomized international study involving 1,702 patients aged 3-59 months with severe pneumonia showed that treatment regimens with the use of parenteral penicillin and oral doses of amoxicillin did not differ in effectiveness.
read more ...